ACCESS Newswire

    / AELF announced today that it has welcomed Alexander “AJ” Issenman to the company as Director of Capital Markets. Issenman joins AELF from Seabury Capital, where he served as a Director at Seabury Capital Management focusing on merchant banking and

    / HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines to treat a wide variety of patients suffering from hard-to-treat solid tumors or hematological malignancies, today announced the acceptance of poster presentation at

    / KEMA Labs, the TIC Division of CESI Group, has enhanced its testing capabilities, significantly boosting the development of HVDC technology. With this expansion, KEMA Labs solidifies its position as a leading independent player in the HVDC Cable testing market,